Dr Frank Bedu Addo | President and Chief Executive Officer
P.D.S. Biotechnology Corp

Dr Frank Bedu Addo, President and Chief Executive Officer, P.D.S. Biotechnology Corp

Dr. Bedu-Addo’s background includes senior executive management roles in drug development, strategy and business operations. He has overseen PDS biotechnology’s operations since inception to the current clinical stage.  He was most recently on the senior executive management team of KBI BioPharma, Inc. where he successfully started up the company’s operations and established a growing industry-leading biotechnology drug development company. Frank started his career as a scientist at The Liposome Company (Elan) in Princeton, NJ. He was responsible for formulation & manufacturing of various products e.g. Abelcet®.  He worked on protein drugs e.g. PEG-Intron® while at Schering-Plough Research Institute, NJ.  Frank has been involved with the development of multiple drug products and patents, and has been invited worldwide to present on various drug development topics.  He has published in leading pharmaceutical journals and been invited to author a chapter on protein drug development.  Frank has been invited by the National Cancer Institute to participate in review of industrial grant applications in the field of nano-therapeutics.  Frank has also been a consultant to top pharmaceutical companies.

back to speakers